{"id":"2e7480c4-6a3d-4bd8-a5d8-f7d76f8135ac","modelId":"1168016f-87f8-408d-9843-cbb596193a5f","versionId":null,"locationId":"15016394-5d51-4c5f-8cbf-329374a3e217","operatorId":"366635c3-c5c3-4b1f-bdb3-f4ce77157a22","ownerId":null,"slug":"remebot-neurosurgical-beijing","status":"operational","firstSeen":"2018-01-01T00:00:00.000Z","statusChangeReason":null,"contractType":null,"pilotOutcome":null,"endedAt":null,"unitsOnSite":null,"tasksPerformed":null,"shiftStructure":null,"hoursPerDay":null,"siteType":null,"operatorConfirmed":null,"humanSupervisionOnsite":null,"locationPrecisionTier":null,"deploymentScale":null,"siteEnvironment":null,"operatorType":null,"sourceQualityTier":null,"manufacturerSerial":null,"reviewStatus":"unreviewed","sources":[{"url":"https://www.nature.com/articles/d42473-020-00264-z","title":"A pioneer in neurosurgical robots","sourceName":"Nature Research Custom Media","publishedAt":"2020-07-29"}],"notes":"First clinical use at PLA Navy General Hospital in Beijing. China's first NMPA-approved neurosurgical robot (2018). Now deployed across 300+ hospitals in 31 provinces with 30,000+ clinical operations (company-reported).","keyFacts":[{"label":"Fleet size","value":"300+ hospitals across 31 provinces (company-reported)"},{"label":"Clinical operations","value":"Over 30,000 (company-reported)"}],"reviewNote":null,"exposureHours":null,"deploymentMilesEstimate":null,"exposureBasis":null,"customerSegment":null,"scaleTier":null,"contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-08-04T01:05:07.107Z","updatedAt":"2026-08-04T01:05:07.107Z","model":{"id":"1168016f-87f8-408d-9843-cbb596193a5f","companyId":"366635c3-c5c3-4b1f-bdb3-f4ce77157a22","modelName":"Remebot","slug":"remebot-neurosurgical","description":"China's first NMPA-approved neurosurgical robot (Class III, 2018). Features a six-axis robotic arm with CT/MRI-compatible visual imaging system, AI-based image identification, and 0.5mm positioning precision guided by an independent optical navigation system. Used for brain biopsy, hematoma drainage, and deep brain stimulation electrode implantation across 300+ hospitals","formFactor":"surgical","industryVertical":"healthcare","environment":"indoor","maturityStage":"production","lifecycleState":"active","supersededByModelId":null,"specs":{"procedures":"biopsy, hematoma drainage, DBS electrode placement","clearance_body":"NMPA","procedure_types":"biopsy, hematoma drainage, DBS electrode placement","regulatory_approval":"NMPA 2018"},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://www.remebot.com.cn/","label":"Remebot Neurosurgical Robot | Beijing Baihui Weikang Technology","title":"Remebot Neurosurgical Robot | Beijing Baihui Weikang Technology","mediaType":"article"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"keyFacts":[{"label":"Form factor","value":"surgical"},{"label":"Regulatory approval","value":"NMPA 2018"},{"label":"Procedures","value":"biopsy, hematoma drainage, DBS electrode placement"},{"label":"Targeting precision","value":"sub-millimeter"}],"createdAt":"2026-06-27T21:36:10.184Z","updatedAt":"2026-08-04T01:04:15.071Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"company":{"id":"366635c3-c5c3-4b1f-bdb3-f4ce77157a22","name":"Remebot","slug":"remebot","description":"Remebot is a Chinese surgical robotics company (Beijing Baihui Weikang Technology Co., Ltd. / 柏惠维康) developing neurosurgical and dental robots for stereotactic procedures. Spun out of Beihang University research led by Wang Tianmiao, the Remebot system became China's first NMPA-approved neurosurgical robot in 2018. Its RM-50 cerebral hemorrhage robot and dental robot have been deployed across 300+ hospitals in 31 provinces, performing over 30,000 clinical operations","status":"active","founded":2010,"hq":"Beijing, China","fundingTotal":null,"type":"both","reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.remebot.com.cn/","title":"Remebot","date_accessed":"2026-06-27"}],"keyFacts":[{"label":"Robot","value":"Remebot, China's first domestic neurosurgical robot"},{"label":"Regulatory","value":"NMPA-approved in 2018"},{"label":"Applications","value":"Used for biopsy, hematoma drainage, and deep-brain-stimulation procedures"},{"label":"Product","value":"Also produces a dental implant robot"},{"label":"Company","value":"Operated by Beijing Baihui Weikang Technology"},{"label":"CEO","value":"Da Liu (刘达)"},{"label":"Founder","value":"Da Liu (刘达), Beihang University spin-out"},{"label":"Research lead","value":"Wang Tianmiao (王田苗), honorary director of Robotics Institute at Beihang University"},{"label":"NMPA approvals","value":"2018 (neurosurgery Class III — first in China), 2021 (oral surgery — first in China), 2022 (RM-50 cerebral hemorrhage)"},{"label":"Cumulative funding","value":"~USD 84.6M (4 rounds per CB Insights; company reports 430M RMB Series D, 600M RMB cumulative)"},{"label":"Clinical operations","value":"Over 30,000 clinical operations across 300+ hospitals in 31 provinces (company-reported)"},{"label":"Products","value":"Remebot Surgical Robot, Remebot Dental Robot, RM-50 cerebral hemorrhage robot"},{"label":"Precision","value":"0.5mm positioning precision with independent optical navigation system"}],"aliases":["Beijing Baihui Weikang Technology","Baihui Weikang"],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-27T12:15:40.963Z","updatedAt":"2026-08-04T01:03:02.364Z"}},"version":null,"location":{"id":"15016394-5d51-4c5f-8cbf-329374a3e217","name":"Beijing, China","slug":"beijing-beijing-china","kind":"city","parentLocationId":null,"region":null,"lat":null,"lng":null,"reviewStatus":"unreviewed","aliases":[],"collisionRisk":"high","reviewNote":null,"createdAt":"2026-08-04T01:05:05.552Z","updatedAt":"2026-08-04T01:05:05.552Z"},"operator":{"id":"366635c3-c5c3-4b1f-bdb3-f4ce77157a22","name":"Remebot","slug":"remebot","description":"Remebot is a Chinese surgical robotics company (Beijing Baihui Weikang Technology Co., Ltd. / 柏惠维康) developing neurosurgical and dental robots for stereotactic procedures. Spun out of Beihang University research led by Wang Tianmiao, the Remebot system became China's first NMPA-approved neurosurgical robot in 2018. Its RM-50 cerebral hemorrhage robot and dental robot have been deployed across 300+ hospitals in 31 provinces, performing over 30,000 clinical operations","status":"active","founded":2010,"hq":"Beijing, China","fundingTotal":null,"type":"both","reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.remebot.com.cn/","title":"Remebot","date_accessed":"2026-06-27"}],"keyFacts":[{"label":"Robot","value":"Remebot, China's first domestic neurosurgical robot"},{"label":"Regulatory","value":"NMPA-approved in 2018"},{"label":"Applications","value":"Used for biopsy, hematoma drainage, and deep-brain-stimulation procedures"},{"label":"Product","value":"Also produces a dental implant robot"},{"label":"Company","value":"Operated by Beijing Baihui Weikang Technology"},{"label":"CEO","value":"Da Liu (刘达)"},{"label":"Founder","value":"Da Liu (刘达), Beihang University spin-out"},{"label":"Research lead","value":"Wang Tianmiao (王田苗), honorary director of Robotics Institute at Beihang University"},{"label":"NMPA approvals","value":"2018 (neurosurgery Class III — first in China), 2021 (oral surgery — first in China), 2022 (RM-50 cerebral hemorrhage)"},{"label":"Cumulative funding","value":"~USD 84.6M (4 rounds per CB Insights; company reports 430M RMB Series D, 600M RMB cumulative)"},{"label":"Clinical operations","value":"Over 30,000 clinical operations across 300+ hospitals in 31 provinces (company-reported)"},{"label":"Products","value":"Remebot Surgical Robot, Remebot Dental Robot, RM-50 cerebral hemorrhage robot"},{"label":"Precision","value":"0.5mm positioning precision with independent optical navigation system"}],"aliases":["Beijing Baihui Weikang Technology","Baihui Weikang"],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-27T12:15:40.963Z","updatedAt":"2026-08-04T01:03:02.364Z"},"owner":null,"derived":{"trustTier":"unverified","currentPosture":null},"jsonLd":{"@context":"https://schema.org","@type":"Event","@id":"https://registry.deploy.report/deployments/remebot-neurosurgical-beijing","url":"https://registry.deploy.report/deployments/remebot-neurosurgical-beijing","name":"Remebot at Beijing, China","identifier":"2e7480c4-6a3d-4bd8-a5d8-f7d76f8135ac","startDate":"2018-01-01T00:00:00.000Z","location":{"@type":"Place","@id":"https://registry.deploy.report/locations/beijing-beijing-china","name":"Beijing, China"},"organizer":{"@type":"Organization","@id":"https://registry.deploy.report/companies/remebot","name":"Remebot"},"about":{"@type":"Product","@id":"https://registry.deploy.report/models/remebot-neurosurgical","name":"Remebot"},"publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"unreviewed","maturity_stage":"production","lifecycle_state":"active","architectural_position":{"cohort":"surgical","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":1,"primary_source_types":["primary-academic-peer-reviewed"]}}}